Deep Dive/ Patients/ Views & Analysis/ Views and analysis A collaborative approach to greater diversity in clinical trials mike.hammerton@pharmaphorum.com clinical trials, data, diversity, Evidera, patients, PPD, trial diversity 0 Comment The need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share X A collaborative approach to greater diversity in clinical trials https://pharmaphorum.com/views-analysis-patients/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
News/ News/ Patients FDA panel backs Sage’s novel antidepressant but turns down Alkermes’ Phil Taylor Alkermes, PPD, Sage, Zulresso 0 Comment Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote Share X FDA panel backs Sage’s novel antidepressant but turns down Alkermes’ https://pharmaphorum.com/news/fda-panel-backs-sages-novel-antidepressant-but-turns-down-alkermes/
clinical trials, data, diversity, Evidera, patients, PPD, trial diversity
0 Comment
